In a recent article from the New York Times, drug approvals could have a faster turnaround if a new bill passes through the House of Representatives. According to the article, “Urged on by the medical industry and patients’ groups, the House overwhelmingly approved a bipartisan bill that would speed federal approval of drugs and medical devices and boost biomedical research.”